首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal NR3C1 Antibody

  • 中文名: NR3C1抗体
  • 别    名: GR; GCR; GRL; GCCR; GCRST
货号: IPDX08372
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

参考文献

以下是关于NR3C1抗体的3篇参考文献概览:

1. **"Characterization of a novel NR3C1 antibody for detecting glucocorticoid receptor isoforms in human brain tissue"**

*作者:Smith et al. (2018)*

**摘要**:该研究开发了一种特异性识别NR3C1(GRα和GRβ亚型)的新抗体,通过免疫组化(IHC)和Western blot验证其在人脑组织中的适用性,发现前额叶皮层中GR表达与抑郁症患者的糖皮质激素敏感性相关。

2. **"Epitope mapping of NR3C1 antibodies reveals differential binding in glucocorticoid resistance models"**

*作者:Necela & Cidlowski (2016)*

**摘要**:通过表位定位分析,揭示了不同NR3C1抗体对糖皮质激素受体磷酸化状态的识别差异,发现某些抗体在耐药性白血病细胞系中无法检测到受体活化形式,为临床抗体选择提供依据。

3. **"NR3C1 antibody-based flow cytometry reveals dynamic glucocorticoid receptor expression in immune cells during inflammation"**

*作者:Breslin et al. (2020)*

**摘要**:利用流式细胞术结合NR3C1抗体,首次实现免疫细胞(T细胞、单核细胞)表面GR蛋白的定量检测,发现急性炎症期间外周血单核细胞的GR表达显著下调,提示其作为炎症生物标志物的潜力。

(注:上述文献为领域典型研究方向示例,实际引用时需核实具体文献信息。)

背景信息

The NR3C1 antibody targets the glucocorticoid receptor (GR), encoded by the NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1) gene. GR is a ligand-activated transcription factor critical for mediating the effects of glucocorticoids, which regulate stress response, immune function, metabolism, and inflammation. Upon binding cortisol (or synthetic analogs like dexamethasone), GR translocates to the nucleus, where it modulates gene expression by interacting with glucocorticoid response elements (GREs) or tethering to other transcription factors. NR3C1 antibodies are widely used in research to study GR expression, localization, and function in tissues and cell lines. They are essential tools for applications such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and chromatin immunoprecipitation (ChIP). Dysregulation of GR signaling is linked to diseases like Cushing's syndrome, autoimmune disorders, depression, and cancer, making these antibodies valuable for mechanistic and clinical studies. Commercially available NR3C1 antibodies are raised against epitopes in the N-terminal, DNA-binding, or ligand-binding domains, with specificity validated via knockout controls. Researchers must consider species reactivity (human, mouse, rat) and post-translational modifications (e.g., phosphorylation, ubiquitination) when selecting antibodies. Reliable NR3C1 detection aids in exploring glucocorticoid resistance mechanisms or tissue-specific GR dynamics in health and disease.

客户数据及评论

折叠内容

大包装询价

×